Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 6 Professional qualifications

1 The clin­ic­al tri­al in­vest­ig­at­or must:

a.
be ad­equately trained in Good Clin­ic­al Prac­tice and have the pro­fes­sion­al know­ledge and ex­per­i­ence re­quired for the clin­ic­al tri­al; and
b.
be con­vers­ant with the leg­al re­quire­ments for clin­ic­al tri­als or be able to en­sure com­pli­ance by call­ing in ap­pro­pri­ate ex­pert­ise.

2 In ad­di­tion, the in­vest­ig­at­or in a clin­ic­al tri­al of medi­cin­al products, products un­der Art­icle 2a para­graph 2 TPA or trans­plant­a­tion must be en­titled to prac­tise the med­ic­al pro­fes­sion in­de­pend­ently.18

3 For clin­ic­al tri­als covered by Chapter 4, a per­son without med­ic­al qual­i­fic­a­tions may also serve as an in­vest­ig­at­or, provided that this per­son is en­titled to prac­tise in­de­pend­ently the pro­fes­sion spe­cific­ally qual­i­fy­ing him or her to con­duct the clin­ic­al tri­al.19

4 The oth­er per­sons con­duct­ing the clin­ic­al tri­al must have the pro­fes­sion­al know­ledge and ex­per­i­ence ap­pro­pri­ate to the activ­it­ies in ques­tion.

18 Amended by An­nex 2 No 2 of the O of 4 May 2022, in force since 26 May 2022 (AS 2022 294).

19 Amended by An­nex 2 No 2 of the O of 4 May 2022, in force since 26 May 2022 (AS 2022 294).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden